TATACHEMChemicals
Tata Chemicals Limited
Current Priceโ‚น670.3(-1.29%)
Market Capโ‚น17,076 Cr
Analysis WindowQ1 FY27
Last Updated29 Jul 2026
Flagium AI Risk Score
Composite forensic risk score based on earnings quality, cash flow, and balance sheet signals. Lower is better.
37/ 100
Risk Rating:Watch
๐ŸŸขQoQ Trend:-22 pts (Risk Decreased)
Business๐ŸŸก Watch
Primary DriverMargin Compression
Valuationsโœ— Demanding
Valuation Score67/100
Market Structureโœ— Weak
Stage 417 sessions

High-quality business currently experiencing weak market structure. Monitor for trend reversal. Valuations remain demanding and supported by current metrics.

Market Alignment
๐ŸŸข ConfirmingMarket behavior remains consistent with deteriorating financial conditions.
Business37/100WatchQoQ Delta: -22 ptsRisk Trend: Improving
ValuationDemandingImplied 87.8% vs -31.0% ObservedValuation Risk: High
Market StructureStage 4 ยท Stage 4 โ€” DecliningRegime Days: 17A/D Flow: Distribution (-0.38ฯƒ)7D Ago Flow: โ€”

What Changed? THIS QUARTER

  • โœ“Risk score improved (QoQ change: -22 pts)
  • โœ—Profitability margins remain stressed
  • โœ—Growth expectations are demanding
  • โœ—Market structure is declining (Stage 4)
  • โ—‹Institutional flow regime is Distribution (-0.38ฯƒ)
  • โœ—Share price is down -6.4% this quarter (from โ‚น715.95 on 30 Jun to โ‚น670.3)

Divergence Radar

BUSINESS STRENGTH63/100
VALUATIONS SURVIVAL (CONSERVATISM)32/100
MARKET TREND STRUCTURE15/100
INSTITUTIONAL FLOW ACCUMULATION41/100

Structural Matrix

Valuation
Business Quality
Low
Balanced
High
Strong
Weak
๐Ÿ”ด

Risk vs Price Timeline
Visualizing the historical relationship between the structural risk score and stock price movement over time.

Loading Chart
Share Price
Risk Score (0-100)
Market Performance
โ‚น670.3(-1.29%)
1M Divergence-9.39%
DurationPerf.Sector AvgDivergence
1 Week-3.09%0%-3.09%
1 Month-8.13%+1.25%-9.39%
6 Months-8.72%+17.09%-25.81%
1 Year-31.94%+4.92%-36.85%
2 Year-38.28%+8.57%-46.85%
3 Year-34.6%+81.31%-115.91%
๐Ÿ’ก

How to Read Business Analysis

Business analysis focuses on structural risk inside the company. Flagium monitors earnings quality, balance sheet strength, liquidity, governance, competitive position, and growth sustainability to identify areas where risk may be increasing or decreasing before it becomes obvious in reported results.

Flagium AI Risk Score37 / 100Riskier than 97.4% of Sector Peers
Risk ClassWatch
Risk Trend-22 QoQ ยท ImprovingRisk score improved (-22 pts)
Risk Acceleration+0 Qtrs
Escalation Prob.5%โœ… NEUTRAL
Interpretation

Financial profile remains stable for now. Pressure is receding in profitability and earnings quality. This suggests the risk profile is currently stabilizing. Risk levels are improving.

Risk Score Composition
Absolute point contribution of each forensic risk driver to the final composite risk score.

Earnings Quality
+15.0 pts
Competitive Position
+15.0 pts
Balance Sheet Stress
+7.0 pts
Final Composite Risk37 / 100

Investment Risk Thesis

Historical Trend

Current risk score has risen from 11 โ†’ 37 over 12 quarters.

Expected Direction
๐ŸŸข Improving
Primary Deterioration Drivers
  • Margin Compression
  • Inventory Stress
  • Relative Growth Weakness
What to Watch Next Quarter
  • Operating profit margins
  • Debt growth
  • Inventory turnover

Risk Drivers (Active Warnings)

Earning Quality
โ– Margin Compression
SEVEREPersistent
โ– Operating Leverage Stress
HIGHPersistent
โ– Profit Collapse
HIGHPersistent

Primary Driver & Insights

Key Contributor
Earning Quality
โ– Margin CompressionSEVERE
Forensic Analyst Insight

Margin Compression is currently the primary contributor to forensic pressure. We advise close monitoring of cash generation and balance sheet quality in upcoming quarters.

Advanced Business Analytics

Active Risk Objects (9)

CriticalHigh
Low Interest Coverage
๐Ÿ’ง Liquidity & CoverageQuarterlyActive for 7 Qtrs
Impact Weight8/15
MomentumPersistent
Last SignalQ1 FY2027
TATACHEM: Low Interest Coverage Ratio of 1.86x in FY2027 Q1 (Threshold: 2.5x).

"Earnings buffer for interest payments is narrowing. Monitor for margin pressure."

Margin Compression
๐Ÿ“Š Earnings QualityAnnualActive for 3 Years
Impact Weight15/15
MomentumPersistent
Last SignalQ1 FY2027
Operating margin declined by 5.4 bps YoY for two consecutive quarters.

"Early signs of margin erosion. Input costs are beginning to eat into core profits."

Inventory Stress
๐Ÿ“Š Earnings QualityAnnualActive for 3 Years
Impact Weight15/15
MomentumDecaying
Last SignalQ4 FY2026
Inventory growth (20.5%) significantly outpaced revenue growth (-1.9%).

"Inventory overhang is clearing. Stock levels are normalizing as sales momentum returns."

Relative Growth Weakness
๐Ÿ“‰ Trend DeteriorationAnnualActive for 5 Years
Impact Weight12/15
MomentumPersistent
Last SignalQ1 FY2027
Revenue growth consistently lags behind sector median (14.1%).

"Earnings quality is under severe pressure. High accruals suggest potential revenue overstatement."

๐ŸŸก HighOperating Leverage Stress
Q1 FY2027
Show Analysis
๐ŸŸก HighWorking Capital Expansion
Q4 FY2026
Show Analysis
๐ŸŸก HighProfit Collapse
Q1 FY2027
Show Analysis
๐ŸŸก HighCapex Efficiency Stress
Q2 FY2025
Show Analysis
๐ŸŸก HighRevenue-Debt Divergence
FY2026
Show Analysis
Risk Trajectory
Historical 12-quarter risk trend (Q-11 to Q0) followed by a 2-quarter predictive funnel (Q+1, Q+2).
Loading Chart
Business Stability
Key indicators of structural risk, cash buffer capability, and risk progression.
Shock ResistanceLow
Escalation RiskLow
Financial StabilityHigh
Margin of SafetyHigh
Forensic Benchmark Context: Chemicals (n=126 peers)

Business Resilience & Benchmark Context

Overall: HEALTHY
Solvency(10)Excellentโ˜…โ˜…โ˜…โ˜…โ˜…
โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ100th %ile
Governance(10)Excellentโ˜…โ˜…โ˜…โ˜…โ˜…
โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ100th %ile
Earnings Quality(0)Weakโ˜…โ˜†โ˜†โ˜†โ˜†
โ–‘โ–‘โ–‘โ–‘โ–‘0th %ile
Balance Sheet Stress(6.5)Fairโ˜…โ˜…โ˜…โ˜†โ˜†
โ–ˆโ–ˆโ–ˆโ–‘โ–‘65th %ile
Competitive Position(0)Weakโ˜…โ˜†โ˜†โ˜†โ˜†
โ–‘โ–‘โ–‘โ–‘โ–‘0th %ile
Growth Sustainability(10)Excellentโ˜…โ˜…โ˜…โ˜…โ˜…
โ–ˆโ–ˆโ–ˆโ–ˆโ–ˆ100th %ile

Deterioration Timeline

2027

Margin Compression

2027

Operating Leverage Stress

2027

Relative Growth Weakness

2026

Operating Leverage Stress

2026

Relative Growth Weakness

2026

Margin Compression

2026

Working Capital Expansion

2026

Inventory Stress

2026

Operating Leverage Stress

2026

Relative Growth Weakness

2026

Relative Growth Weakness

2026

Inventory Stress

2026

Relative Growth Weakness

2026

Revenue-Debt Divergence

2025

Margin Compression

2025

Inventory Stress

2025

Working Capital Expansion

2025

Capex Efficiency Stress

2025

Revenue-Debt Divergence

2024

Capex Efficiency Stress

Key Financials (INR Cr)

Revenue Trend
Decliningโ†“
Profitability
Weakeningโ†“
Cash Generation
Weakeningโ†“
Debt Trend
Risingโ†‘
PeriodRevenueEBITDANet ProfitCFODebt
FY202614,900165-1,7151,2698,001
FY202515,1122,0533871,7617,072
FY202415,7072,2724353,0165,563
FY202317,0074,0402,4342,9716,296
FY202212,8782,5501,4051,644-
3Y Growth Snapshot-12%-96%-170%-57%+27%
Sentinel Forensic AssessmentALGORITHMIC RISK PROFILE โ€ข NON-ADVISORY
Fundamental Status

Business quality remains stable.

Forensic Pressure

Current forensic pressure is elevated and improving.

Primary Risk Vectors

Key risks remain concentrated in growth sustainability and operating leverage.

The risk profile is Early Signals and currently improving. Recent structural triggers in earnings quality suggest a building pressure on the underlying framework. Material forensic traces are visible in operational margins and profitability metrics, indicating a progressive erosion of structural stability. Initial structural recovery is visible; monitor for a sustained return to resilience.

MARKET EXPECTATION ENGINE
DEMANDING EXPECTATIONS
๐Ÿ’ก

How to read this

We calculate the future growth rate the market is currently expecting and compare it to the company's historical delivery. A higher required growth target indicates more demanding market expectations and elevated expectation risk.

Sentinel InsightsThe market expects future growth significantly above the company's historical delivery. Current market expectations appear demanding relative to the business's track record, resulting in higher expectation risk.

Market-Implied Growth87.8%Future Growth Needed
Historical Delivery-31.0%Actual Past Growth
Expectation Gap+118.9%Growth Jump Needed
Expectation Risk Score67/100Price Risk Score
CONSERVATIVE (-33%)BALANCEDDEMANDING (90%)
Historical (-31.0%)
Market (87.8%)
Valuation Summary

Using the Discounted Cash Flow (DCF) model, the market is pricing TATACHEM for 87.8% long-term growth versus -31.0% historical delivery. Current expectations appear demanding, and historical fundamentals provide limited support.

Business Delivery Capacity

Performance quality vs historical benchmarks
Historical Delivery Audit
Revenue Growth SupportObserved CAGR vs cost of capital baseline
-31.0% CAGR
โœ— Weak
Operating Profitability SupportEBIT margins compared to historical standards
5.3% Margin
โœ— Weak Margin
Cash Flow Generation SupportOperating cash flow conversion and support cushion
14.2% Conv
โœ“ Positive
Capital Leverage RiskLeverage indicators and solvency pressure
Pressure
โœ— Leverage Risk
Delivery Capacity Index
30/100
LOW CAPACITY

Historical business performance currently provides limited support for the market's implied growth assumptions. Improvement in revenue growth and operating efficiency would strengthen expectation support.

WHY IS EXPECTATION RISK ELEVATED?

Risk Drivers:
โœ“High implied growth
โœ“Weak historical delivery
โœ“Expensive valuation regime
โœ“Weak profitability support

Valuation Context

Historical Valuation59th percentile
Cash Yield Support0.37% (Weak)
Sector Premium+5430% EV/EBITDA
Current Valuation RegimeDemanding

WHAT MUST HAPPEN FOR CURRENT PRICE TO BE CORRECT?

MARKET REQUIRED METRICS
Assumption MetricRequired (To justify current price)Historical Delivery (Average)Fulfillment Assessment
Revenue Growth (CAGR)87.8%-31.0%Aggressive
Operating Margin (EBIT)0.9%5.3%Achievable
Free Cash Flow Conversion46.0%14.2%Aggressive

*Required metrics indicate the operating efficiency and revenue expansion parameters that must be sustained long-term to justify the current stock price.

Advanced Valuation Analytics
Sentinel Expectation Assessment

The current valuation assumes business performance well above the company's historical record. Historical operating performance currently provides limited evidence that these expectations are sustainable. Continued revenue acceleration and stronger profitability would be required to justify current pricing.

๐Ÿ’ก

How to read Market Structure

Flagium separates Business Risk from Market Structure. Business analysis explains what is happening inside the company. Market Structure measures how investors are behaving through price trends, momentum, participation, and institutional activity. Divergences between the two often reveal important transitions before they become obvious.

Market Structure
STAGE 4
DECLININGBEAR CYCLE
Stage Progress
Measures the progress of the stock's current price, volume, and momentum characteristic alignments.
0%
TrendDeclining
MomentumNeutral
ParticipationNeutral
A/D FlowNeutral
Sentinel Market Insight

The stock remains in a confirmed Stage 4 declining phase. Institutional participation remains distribution, while trend quality stays weak and momentum continues to deteriorate. Current price action does not yet confirm a structural recovery.

What Is Driving Market Structure?

Market Drivers
โœ—Long-term trend remains below the 150DMA
โœ—Long-term trend remains below the 200DMA
โœ—RS continues to lag the market
โ—‹Institutional flow remains neutral
โœ—Momentum remains negative
Summary
๐ŸŸขConfirming

Market behavior remains consistent with deteriorating financial conditions.

Weinstein Stage Analysis

S1
Accumulation
S2
Advancing
S3
Distribution
S4
Declining
Stage Lifecycle
Stage Progress
0%
Readiness LabelLow (Early Base Consolidation)
Regime Sessions17 Sessions
Transition Probability0% Low
Measures the alignment and consistency of the stock's price trend relative to its historical volume volatility.
0.7788ฯƒ Weak
Trend & Strength
Trend QualityDeteriorating
150 DMA Slope-1.2268%
Participation & Volume
Avg Turnover (200D)โ‚น67.2 Cr
Liquidity RatingLow Liquidity
ParticipationWeak

Momentum & Institutional Flow

Price Momentum
Momentum StrengthWeakening momentum trend
Price momentum score in standard deviations (ฯƒ). Readings beyond ยฑ2.0ฯƒ indicate extreme momentum shifts.
-0.3730ฯƒ
Universe Rank
#2156 of 2792Bottom 22.78% in momentum strength
Institutional Accumulation
21D Flow Score
21-day cumulative institutional flow score in standard deviations (ฯƒ).
-0.38ฯƒ
7D Flow TrendNeutral
TATACHEM

Market Structure Analysis

Explore how each market indicator contributes to the current stage classification.

No market structure history available.
Methodology & Disclaimer

These analytics are derived from quantitative analysis of historical price, volume, and market participation data and are intended solely for informational and research purposes. They do not constitute investment advice, recommendations, or guarantees of future performance.